Detalles de la búsqueda
1.
Efficacy and safety of bivalent RSVpreF maternal vaccination to prevent RSV illness in Japanese infants: Subset analysis from the pivotal randomized phase 3 MATISSE trial.
Vaccine
; 2024 Jun 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38853036
2.
Phase 3 immunogenicity and safety study of a tick-borne encephalitis vaccine in healthy Japanese participants 1 year of age and older.
Vaccine
; 42(13): 3180-3189, 2024 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38614954
3.
A phase 3 randomized trial of the safety and immunogenicity of 20-valent pneumococcal conjugate vaccine in adultsâ¯≥â¯60 years of age in Japan, South Korea, and Taiwan.
Vaccine
; 42(5): 1071-1077, 2024 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38267330
4.
A phase 3 randomized study to evaluate safety and immunogenicity of 20-valent pneumococcal conjugate vaccine in healthy Japanese infants.
Int J Infect Dis
; 141: 106942, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38242195
5.
A randomized study to evaluate safety and immunogenicity of the BNT162b2 COVID-19 vaccine in healthy Japanese adults.
Nat Commun
; 12(1): 7105, 2021 12 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34907170
6.
A phase 3, multicenter, single-arm, open-label study to assess the safety, tolerability, and immunogenicity of a single dose of 13-valent pneumococcal conjugate vaccine in Japanese participants aged 6-64 years who are considered to be at increased risk of pneumococcal disease and who are naive to pneumococcal vaccines.
Vaccine
; 39(43): 6414-6421, 2021 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34563397
7.
A phase 1 randomized study assessing safety and immunogenicity of two 3-dose regimens of a Clostridium difficile vaccine in healthy older Japanese adults.
Vaccine
; 37(19): 2600-2607, 2019 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30962095
8.
Safety, tolerability, and immunogenicity of a novel 4-antigen Staphylococcus aureus vaccine (SA4Ag) in healthy Japanese adults.
Hum Vaccin Immunother
; 14(11): 2682-2691, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30084709
9.
Immunogenicity and Safety of a 13-Valent Pneumococcal Conjugate Vaccine Given With DTaP Vaccine in Healthy Infants in Japan.
Pediatr Infect Dis J
; 34(10): 1096-104, 2015 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26121200
10.
Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine when administered to healthy Japanese adults aged ≥50 years. An open-label trial.
Hum Vaccin Immunother
; 10(7): 1850-8, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25424792
11.
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in healthy infants in Japan.
Pediatr Infect Dis J
; 32(9): 984-9, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23538524
12.
SKIP modifies gene expression by affecting both transcription and splicing.
Biochem Biophys Res Commun
; 316(2): 512-7, 2004 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-15020246
Resultados
1 -
12
de 12
1
Próxima >
>>